Jumat, 18 September 2026 - 10:04 WIB

Find and Follow Us

Global Markets

IHSG 6,231.78 +0.00%

S&P 500 7,443.28 -0.19%

NASDAQ 25,508.07 -0.05%

Dow Jones 51,839.26 -0.59%

FTSE 100 10,524.80 -0.71%

CAC 40 8,340.11 +0.02%

Nikkei 225 65,193.75 +1.64%

Hang Seng 25,111.29 -0.13%

Shanghai 3,779.30 -0.45%

KOSPI 6,712.12 +3.01%

STI 5,513.85 +0.27%

ASX 200 8,766.60 -0.28%

Sensex 77,708.52 -0.57%

Gold 4,030.20 +0.44%

Silver 57.26 +2.17%

Oil (WTI) 82.30 -0.23%

Brent 88.63 +0.60%

Copper 6.37 +2.33%

Gas Alam 2.85 -2.27%

Bitcoin 65,194.22 +0.00%

Ethereum 1,906.44 +0.00%

USD/IDR 17,971.00 +0.21%

EUR/USD 1.14 -0.08%

QurCan Therapeutics

Gandeng Lilly, QurCan Raih Potensi US$237 Juta Per Program

Redaksi • 18 September 2026

Latest Updates

QurCan Therapeutics

07:56 WIB • 18 September 2026

Gandeng Lilly, QurCan Raih Potensi US$237 Juta Per Program

QurCan Therapeutics mengumumkan perjanjian eksklusif riset dan kerja sama dengan Eli Lilly and Company untuk terapi penyakit…